The serum concentration of Pefloxacin can be decreased when it is combined with MAGNESIUM SULFATE.


The serum concentration of methadone can be decreased when it is combined with Dabrafenib.


The serum concentration of ipratropium can be decreased when it is combined with Dabrafenib.


The serum concentration of Gefitinib can be decreased when it is combined with Aluminium hydroxide.


The serum concentration of Pimecrolimus can be decreased when it is combined with Dabrafenib.


The serum concentration of Maraviroc can be decreased when it is combined with Brigatinib.


The serum concentration of pyrazinamide can be decreased when it is combined with Dabrafenib.


The serum concentration of omeprazole can be decreased when it is combined with Dabrafenib.


The serum concentration of VALPROIC ACID can be decreased when it is combined with SAQUINAVIR.


The serum concentration of ouabain can be decreased when it is combined with gentamicin.


The serum concentration of menadione can be decreased when it is combined with Teriflunomide.


The serum concentration of fluvoxamine can be decreased when it is combined with Teriflunomide.


The serum concentration of Aripiprazole can be decreased when it is combined with alclometasone.


The serum concentration of haloprogin can be decreased when it is combined with Fosphenytoin.


The serum concentration of Delavirdine can be decreased when it is combined with Apixaban.


The serum concentration of diethylstilbestrol can be decreased when it is combined with Apixaban.


The serum concentration of atorvastatin can be decreased when it is combined with Bexarotene.


The serum concentration of Clevidipine can be decreased when it is combined with Teriflunomide.


The serum concentration of Tiludronic Acid can be decreased when it is combined with Magnesium trisilicate.


The serum concentration of itraconazole can be decreased when it is combined with cimetidine.


The serum concentration of Rilpivirine can be decreased when it is combined with Perampanel.


The serum concentration of Elvitegravir can be decreased when it is combined with Trometamol.


The serum concentration of Drospirenone can be decreased when it is combined with Darunavir.


The serum concentration of deslanoside can be decreased when it is combined with kanamycin.


The serum concentration of estramustine can be decreased when it is combined with Linagliptin.


The serum concentration of Pipotiazine can be decreased when it is combined with Bosentan.


The serum concentration of itraconazole can be decreased when it is combined with pantoprazole.


The serum concentration of Dasatinib can be decreased when it is combined with Lumacaftor.


The serum concentration of ETONOGESTREL can be decreased when it is combined with felbamate.


The serum concentration of Etoricoxib can be decreased when it is combined with Bosentan.


The serum concentration of itraconazole can be decreased when it is combined with isoniazid.


The serum concentration of carbamazepine can be decreased when it is combined with Deferasirox.


The serum concentration of Rolapitant can be decreased when it is combined with primidone.


The serum concentration of cephalexin can be decreased when it is combined with Deferasirox.


The serum concentration of Delavirdine can be decreased when it is combined with Trometamol.


The serum concentration of Dronedarone can be decreased when it is combined with Lumacaftor.


The serum concentration of itraconazole can be decreased when it is combined with nizatidine.


The serum concentration of Zuclopenthixol can be decreased when it is combined with primidone.


The serum concentration of itraconazole can be decreased when it is combined with Enzalutamide.


The serum concentration of cilostazol can be decreased when it is combined with Enzalutamide.


The serum concentration of enoxacin can be decreased when it is combined with FERRIC PYROPHOSPHATE.


The serum concentration of nimesulide can be decreased when it is combined with Rifampicin.


The serum concentration of simvastatin can be decreased when it is combined with SODIUM BICARBONATE.


The serum concentration of ribostamycin can be decreased when it is combined with PENICILLIN G PROCAINE.


The serum concentration of Canagliflozin can be decreased when it is combined with Deferasirox.


The serum concentration of Lenvatinib can be decreased when it is combined with Deferasirox.


The serum concentration of tobramycin can be decreased when it is combined with dicloxacillin.


The serum concentration of streptomycin can be decreased when it is combined with ampicillin.


The serum concentration of losartan can be decreased when it is combined with mitotane.


The serum concentration of galanthamine can be decreased when it is combined with mitotane.


The serum concentration of tamoxifen can be decreased when it is combined with mitotane.


The serum concentration of Aprepitant can be decreased when it is combined with mitotane.


The serum concentration of Pitavastatin can be decreased when it is combined with SODIUM BICARBONATE.


The serum concentration of griseofulvin can be decreased when it is combined with thiopental.


The serum concentration of CLOBETASOL PROPIONATE can be decreased when it is combined with Fosphenytoin.


The serum concentration of Ibandronic Acid can be decreased when it is combined with Iron sucrose.


The serum concentration of Delavirdine can be decreased when it is combined with Almasilate.


The serum concentration of aminophylline can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of SULFAMOXOLE can be decreased when it is combined with Dabrafenib.


The serum concentration of isoniazid can be decreased when it is combined with fludrocortisone.


The serum concentration of nitrofurantoin can be decreased when it is combined with Magnesium trisilicate.


The serum concentration of fluocinonide can be decreased when it is combined with primidone.


The serum concentration of warfarin can be decreased when it is combined with carbamazepine.


The serum concentration of Telaprevir can be decreased when it is combined with prednisone.


The serum concentration of fludrocortisone can be decreased when it is combined with carbamazepine.


The serum concentration of Copanlisib can be decreased when it is combined with mitotane.


The serum concentration of Linagliptin can be decreased when it is combined with midazolam.


The serum concentration of SERATRODAST can be decreased when it is combined with Deferasirox.


The serum concentration of Ketobemidone can be decreased when it is combined with Deferasirox.


The serum concentration of phenoxybenzamine can be decreased when it is combined with Bosentan.


The serum concentration of Escitalopram can be decreased when it is combined with Telaprevir.


The serum concentration of atorvastatin can be decreased when it is combined with Trometamol.


The serum concentration of Etidronic acid can be decreased when it is combined with Trometamol.


The serum concentration of mycophenolic acid can be decreased when it is combined with MAGNESIUM HYDROXIDE.


The serum concentration of ketoconazole can be decreased when it is combined with MAGNESIUM HYDROXIDE.


The serum concentration of Aprepitant can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of tamoxifen can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of estramustine can be decreased when it is combined with mycophenolic acid.


The serum concentration of buprenorphine can be decreased when it is combined with Bosentan.


The serum concentration of Lomitapide can be decreased when it is combined with Deferasirox.


The serum concentration of Vismodegib can be decreased when it is combined with Deferasirox.


The serum concentration of Quinine can be decreased when it is combined with carbamazepine.


The serum concentration of benzoic acid can be decreased when it is combined with Fosphenytoin.


The serum concentration of Etidronic acid can be decreased when it is combined with CALCIUM CHLORIDE.


The serum concentration of Telaprevir can be decreased when it is combined with betamethasone.


The serum concentration of netilmicin can be decreased when it is combined with dicloxacillin.


The serum concentration of acetaminophen can be decreased when it is combined with Fosphenytoin.


The serum concentration of Rilpivirine can be decreased when it is combined with Eletriptan.


The serum concentration of Abiraterone can be decreased when it is combined with Lumacaftor.


The serum concentration of Panobinostat can be decreased when it is combined with Bosentan.


The serum concentration of Apixaban can be decreased when it is combined with Bosentan.


The serum concentration of zaleplon can be decreased when it is combined with Bosentan.


The serum concentration of Delavirdine can be decreased when it is combined with Asunaprevir.


The serum concentration of streptozocin can be decreased when it is combined with Pivmecillinam.


The serum concentration of diethylstilbestrol can be decreased when it is combined with Asunaprevir.


The serum concentration of metronidazole can be decreased when it is combined with primidone.


The serum concentration of Levetiracetam can be decreased when it is combined with orlistat.


The serum concentration of Macitentan can be decreased when it is combined with Dabrafenib.


The serum concentration of Riociguat can be decreased when it is combined with Dabrafenib.


The serum concentration of Temsirolimus can be decreased when it is combined with mitotane.


The serum concentration of Afatinib can be decreased when it is combined with vinblastine.


The serum concentration of warfarin can be decreased when it is combined with mitotane.


The serum concentration of deslanoside can be decreased when it is combined with metrizamide.


The serum concentration of Pregabalin can be decreased when it is combined with Rifaximin.


The serum concentration of fexofenadine can be decreased when it is combined with MAGNESIUM HYDROXIDE.


The serum concentration of pravastatin can be decreased when it is combined with efavirenz.


The serum concentration of fenofibrate can be decreased when it is combined with Bosentan.


The serum concentration of Treprostinil can be decreased when it is combined with phenobarbital.


The serum concentration of phenytoin can be decreased when it is combined with VALPROIC ACID.


The serum concentration of dienestrol can be decreased when it is combined with Spirapril.


The serum concentration of ethinyl estradiol can be decreased when it is combined with Armodafinil.


The serum concentration of aminophylline can be decreased when it is combined with carbamazepine.


The serum concentration of perphenazine can be decreased when it is combined with mitotane.


The serum concentration of Ixabepilone can be decreased when it is combined with phenytoin.


The serum concentration of Enasidenib can be decreased when it is combined with mitotane.


The serum concentration of metrizamide can be decreased when it is combined with PENICILLIN G PROCAINE.


The serum concentration of metrizamide can be decreased when it is combined with dicloxacillin.


The serum concentration of ADINAZOLAM can be decreased when it is combined with Vemurafenib.


The serum concentration of norgestrel can be decreased when it is combined with Bosentan.


The serum concentration of zafirlukast can be decreased when it is combined with Vemurafenib.


The serum concentration of barnidipine can be decreased when it is combined with RIFABUTIN.


The serum concentration of Pregabalin can be decreased when it is combined with orlistat.


The serum concentration of VALPROIC ACID can be decreased when it is combined with imipenem.


The serum concentration of flunarizine can be decreased when it is combined with phenytoin.


The serum concentration of zidovudine can be decreased when it is combined with trandolapril.


The serum concentration of Ruxolitinib can be decreased when it is combined with Vemurafenib.


The serum concentration of Cabozantinib can be decreased when it is combined with Vemurafenib.


The serum concentration of Boceprevir can be decreased when it is combined with Vemurafenib.


The serum concentration of Saxagliptin can be decreased when it is combined with reserpine.


The serum concentration of Cinacalcet can be decreased when it is combined with Bosentan.


The serum concentration of Valrubicin can be decreased when it is combined with cloxacillin.


The serum concentration of rapamycin can be decreased when it is combined with mitotane.


The serum concentration of paromomycin can be decreased when it is combined with penicillin g.


The serum concentration of Conivaptan can be decreased when it is combined with mitotane.


The serum concentration of loteprednol can be decreased when it is combined with mitotane.


The serum concentration of ketoprofen can be decreased when it is combined with Lumacaftor.


The serum concentration of quinacrine can be decreased when it is combined with amodiaquine.


The serum concentration of PAMIDRONIC ACID can be decreased when it is combined with Aluminium.


The serum concentration of ribostamycin can be decreased when it is combined with TICARCILLIN.


The serum concentration of ergocalciferol can be decreased when it is combined with orlistat.


The serum concentration of abacavir can be decreased when it is combined with EDOXABAN.


The serum concentration of ethinyl estradiol can be decreased when it is combined with Ximelagatran.


The serum concentration of oxiconazole can be decreased when it is combined with Lumacaftor.


The serum concentration of nevirapine can be decreased when it is combined with Lumacaftor.


The serum concentration of Pomalidomide can be decreased when it is combined with Enzalutamide.


The serum concentration of mestranol can be decreased when it is combined with indinavir.


The serum concentration of Riociguat can be decreased when it is combined with dexlansoprazole.


The serum concentration of Clodronic Acid can be decreased when it is combined with Calcium acetate.


The serum concentration of cinnarizine can be decreased when it is combined with RIFABUTIN.


The serum concentration of Cobicistat can be decreased when it is combined with phenytoin.


The serum concentration of Tasimelteon can be decreased when it is combined with Lumacaftor.


The serum concentration of Palbociclib can be decreased when it is combined with Lumacaftor.


The serum concentration of Olaparib can be decreased when it is combined with Lumacaftor.


The serum concentration of UMECLIDINIUM can be decreased when it is combined with Lumacaftor.


The serum concentration of Lenvatinib can be decreased when it is combined with Lumacaftor.


The serum concentration of Nintedanib can be decreased when it is combined with Lumacaftor.


The serum concentration of Telaprevir can be decreased when it is combined with Boceprevir.


The serum concentration of VORTIOXETINE can be decreased when it is combined with phenytoin.


The serum concentration of Valrubicin can be decreased when it is combined with methicillin.


The serum concentration of celecoxib can be decreased when it is combined with Deferasirox.


The serum concentration of raloxifene can be decreased when it is combined with Deferasirox.


The serum concentration of tacrolimus can be decreased when it is combined with Sevelamer.


The serum concentration of bezafibrate can be decreased when it is combined with Enzalutamide.


The serum concentration of digitoxin can be decreased when it is combined with Enzalutamide.


The serum concentration of colchicine can be decreased when it is combined with Enzalutamide.


The serum concentration of oxycodone can be decreased when it is combined with Bosentan.


The serum concentration of zidovudine can be decreased when it is combined with Bosentan.


The serum concentration of buspirone can be decreased when it is combined with Bosentan.


The serum concentration of Delavirdine can be decreased when it is combined with Rifampicin.


The serum concentration of Ulipristal can be decreased when it is combined with pentobarbital.


The serum concentration of methyldopa can be decreased when it is combined with FERRIC CITRATE.


The serum concentration of Rilpivirine can be decreased when it is combined with pentobarbital.


The serum concentration of Daclatasvir can be decreased when it is combined with carbamazepine.


The serum concentration of doxepin can be decreased when it is combined with Teriflunomide.


The serum concentration of Idelalisib can be decreased when it is combined with phenobarbital.


The serum concentration of Pazopanib can be decreased when it is combined with Bismuth subcitrate potassium.


The serum concentration of abacavir can be decreased when it is combined with fosinopril.


The serum concentration of nitric oxide can be decreased when it is combined with osimertinib.


The serum concentration of gabapentin can be decreased when it is combined with Magnesium trisilicate.


The serum concentration of estramustine can be decreased when it is combined with Boceprevir.


The serum concentration of captopril can be decreased when it is combined with Boceprevir.


The serum concentration of metrizamide can be decreased when it is combined with MEZLOCILLIN.


The serum concentration of IMIQUIMOD can be decreased when it is combined with Bosentan.


The serum concentration of trimipramine can be decreased when it is combined with Bosentan.


The serum concentration of methylprednisolone can be decreased when it is combined with Deferasirox.


The serum concentration of nifedipine can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of amiodarone can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of HYDROCODONE can be decreased when it is combined with Deferasirox.


The serum concentration of ROSOXACIN can be decreased when it is combined with MAGNESIUM SULFATE.


The serum concentration of Nilotinib can be decreased when it is combined with dexlansoprazole.


The serum concentration of demeclocycline can be decreased when it is combined with CALCIUM GLUCONATE.


The serum concentration of pilocarpine can be decreased when it is combined with mitotane.


The serum concentration of fluvastatin can be decreased when it is combined with phenytoin.


The serum concentration of Rosuvastatin can be decreased when it is combined with phenytoin.


The serum concentration of Neratinib can be decreased when it is combined with Dabrafenib.


The serum concentration of Ospemifene can be decreased when it is combined with Dabrafenib.


The serum concentration of Posaconazole can be decreased when it is combined with Asenapine.


The serum concentration of mianserin can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of Permethrin can be decreased when it is combined with Dabrafenib.


The serum concentration of METHAMPHETAMINE can be decreased when it is combined with methenamine.


The serum concentration of dextroamphetamine can be decreased when it is combined with methenamine.


The serum concentration of flurandrenolide can be decreased when it is combined with RIFABUTIN.


The serum concentration of Saxagliptin can be decreased when it is combined with ritonavir.


The serum concentration of Fosamprenavir can be decreased when it is combined with cimetidine.


The serum concentration of fleroxacin can be decreased when it is combined with Sucralfate.


The serum concentration of methadone can be decreased when it is combined with nelfinavir.


The serum concentration of diethylstilbestrol can be decreased when it is combined with Prucalopride.


The serum concentration of equilin can be decreased when it is combined with primidone.


The serum concentration of fluocinonide can be decreased when it is combined with phenobarbital.


The serum concentration of Bendamustine can be decreased when it is combined with Teriflunomide.


The serum concentration of mifepristone can be decreased when it is combined with Lumacaftor.


The serum concentration of Axitinib can be decreased when it is combined with Rifampicin.


The serum concentration of Ziprasidone can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of Aripiprazole can be decreased when it is combined with fluvastatin.


The serum concentration of CLOCORTOLONE can be decreased when it is combined with Lumacaftor.


The serum concentration of VALPROIC ACID can be decreased when it is combined with Boceprevir.


The serum concentration of Linagliptin can be decreased when it is combined with daunorubicin.


The serum concentration of Linagliptin can be decreased when it is combined with amiodarone.


The serum concentration of didanosine can be decreased when it is combined with ROSOXACIN.


The serum concentration of zolpidem can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of HYDROCODONE can be decreased when it is combined with Vemurafenib.


The serum concentration of lovastatin can be decreased when it is combined with Vemurafenib.


The serum concentration of Vorapaxar can be decreased when it is combined with RIFABUTIN.


The serum concentration of estradiol can be decreased when it is combined with Lumacaftor.


The serum concentration of Suvorexant can be decreased when it is combined with RIFABUTIN.


The serum concentration of ELIGLUSTAT can be decreased when it is combined with RIFABUTIN.


The serum concentration of rapamycin can be decreased when it is combined with phenytoin.


The serum concentration of plicamycin can be decreased when it is combined with PENICILLIN G PROCAINE.


The serum concentration of felodipine can be decreased when it is combined with Brigatinib.


The serum concentration of loteprednol can be decreased when it is combined with phenytoin.


The serum concentration of streptozocin can be decreased when it is combined with PENICILLIN G PROCAINE.


The serum concentration of Dabigatran etexilate can be decreased when it is combined with Trometamol.


The serum concentration of RIMEXOLONE can be decreased when it is combined with carbamazepine.


The serum concentration of mycophenolic acid can be decreased when it is combined with Pefloxacin.


The serum concentration of Fluprednidene can be decreased when it is combined with nevirapine.


The serum concentration of FLUOCORTOLONE can be decreased when it is combined with nevirapine.


The serum concentration of GESTODENE can be decreased when it is combined with felbamate.


The serum concentration of Rilpivirine can be decreased when it is combined with OXCARBAZEPINE.


The serum concentration of Ulipristal can be decreased when it is combined with OXCARBAZEPINE.


The serum concentration of Venetoclax can be decreased when it is combined with Enzalutamide.


The serum concentration of sulfadiazine can be decreased when it is combined with Enzalutamide.


The serum concentration of mefloquine can be decreased when it is combined with Enzalutamide.


The serum concentration of cisapride can be decreased when it is combined with Enzalutamide.


The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Enzalutamide.


The serum concentration of IVERMECTIN can be decreased when it is combined with Enzalutamide.


The serum concentration of chloroquine can be decreased when it is combined with Enzalutamide.


The serum concentration of Saxagliptin can be decreased when it is combined with temozolomide.


The serum concentration of Dronedarone can be decreased when it is combined with Enzalutamide.


The serum concentration of Estrone sulfate can be decreased when it is combined with Bivalirudin.


The serum concentration of Nilotinib can be decreased when it is combined with MAGNESIUM OXIDE.


The serum concentration of Aripiprazole can be decreased when it is combined with gemfibrozil.


The serum concentration of aminophylline can be decreased when it is combined with fosinopril.


The serum concentration of propafenone can be decreased when it is combined with primidone.


The serum concentration of metronidazole can be decreased when it is combined with phenytoin.


The serum concentration of sotalol can be decreased when it is combined with Magnesium trisilicate.


The serum concentration of fludrocortisone can be decreased when it is combined with pentobarbital.


The serum concentration of cyclosporin A can be decreased when it is combined with carbamazepine.


The serum concentration of ACENOCOUMAROL can be decreased when it is combined with carbamazepine.


The serum concentration of Linagliptin can be decreased when it is combined with reserpine.


The serum concentration of estradiol can be decreased when it is combined with Prucalopride.


The serum concentration of phenoxybenzamine can be decreased when it is combined with Enzalutamide.


The serum concentration of Lumiracoxib can be decreased when it is combined with Teriflunomide.


The serum concentration of Aripiprazole can be decreased when it is combined with SERATRODAST.


The serum concentration of nalidixic acid can be decreased when it is combined with FERRIC CITRATE.


The serum concentration of Dipotassium hydrogen phosphate can be decreased when it is combined with Magnesium salicylate.


The serum concentration of ropinirole can be decreased when it is combined with Bosentan.


The serum concentration of liothyronine can be decreased when it is combined with ciprofloxacin.


The serum concentration of warfarin can be decreased when it is combined with ethanol.


The serum concentration of Risedronic acid can be decreased when it is combined with Calcium phosphate.


The serum concentration of nisoldipine can be decreased when it is combined with nevirapine.


The serum concentration of ketoconazole can be decreased when it is combined with Fosphenytoin.


The serum concentration of chlortetracycline can be decreased when it is combined with CALCIUM CHLORIDE.


The serum concentration of daunorubicin can be decreased when it is combined with amoxicillin.


The serum concentration of Rotigotine can be decreased when it is combined with Deferasirox.


The serum concentration of Indacaterol can be decreased when it is combined with Bosentan.


The serum concentration of phenobarbital can be decreased when it is combined with folinic acid.


The serum concentration of Posaconazole can be decreased when it is combined with metoclopramide.


The serum concentration of vincristine can be decreased when it is combined with nevirapine.


The serum concentration of minocycline can be decreased when it is combined with Iron sucrose.


The serum concentration of desoximetasone can be decreased when it is combined with nevirapine.


The serum concentration of Saxagliptin can be decreased when it is combined with Oritavancin.


The serum concentration of estradiol can be decreased when it is combined with benazepril.


The serum concentration of Dienogest can be decreased when it is combined with Rifampicin.


The serum concentration of ethinyl estradiol can be decreased when it is combined with PERINDOPRIL.


The serum concentration of estazolam can be decreased when it is combined with mitotane.


The serum concentration of doxorubicin can be decreased when it is combined with Flucloxacillin.


The serum concentration of Afatinib can be decreased when it is combined with doxorubicin.


The serum concentration of ALENDRONIC ACID can be decreased when it is combined with Aluminium.


The serum concentration of Epirubicin can be decreased when it is combined with amoxicillin.


The serum concentration of oxamniquine can be decreased when it is combined with PRIMAQUINE.


The serum concentration of sulfadiazine can be decreased when it is combined with Dabrafenib.


The serum concentration of mefloquine can be decreased when it is combined with Dabrafenib.


The serum concentration of Saxagliptin can be decreased when it is combined with Delafloxacin.


The serum concentration of Saxagliptin can be decreased when it is combined with Clevidipine.


The serum concentration of tobramycin can be decreased when it is combined with piperacillin.


The serum concentration of chlorzoxazone can be decreased when it is combined with Dabrafenib.


The serum concentration of Roflumilast can be decreased when it is combined with RIFAPENTINE.


The serum concentration of guanabenz can be decreased when it is combined with Teriflunomide.


The serum concentration of diethylstilbestrol can be decreased when it is combined with SIMEPREVIR.


The serum concentration of Asenapine can be decreased when it is combined with Dabrafenib.


The serum concentration of dienestrol can be decreased when it is combined with nevirapine.


The serum concentration of Eltrombopag can be decreased when it is combined with Dabrafenib.


The serum concentration of zidovudine can be decreased when it is combined with indinavir.


The serum concentration of Tolvaptan can be decreased when it is combined with Dabrafenib.


The serum concentration of ALENDRONIC ACID can be decreased when it is combined with CALCIUM CARBONATE.


The serum concentration of Riociguat can be decreased when it is combined with Almasilate.


The serum concentration of etoposide can be decreased when it is combined with Fosphenytoin.


The serum concentration of Dabrafenib can be decreased when it is combined with olanzapine.


The serum concentration of Afatinib can be decreased when it is combined with Liotrix.


The serum concentration of Regorafenib can be decreased when it is combined with carbamazepine.


The serum concentration of Tofacitinib can be decreased when it is combined with carbamazepine.


The serum concentration of Vemurafenib can be decreased when it is combined with carbamazepine.


The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.


The serum concentration of mestranol can be decreased when it is combined with Bosentan.


The serum concentration of doxorubicin can be decreased when it is combined with TICARCILLIN.


The serum concentration of Hexobarbital can be decreased when it is combined with Bosentan.


The serum concentration of gentamicin can be decreased when it is combined with Penicillin G benzathine.


The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Telaprevir.


The serum concentration of Arformoterol can be decreased when it is combined with Lumacaftor.


The serum concentration of dantrolene can be decreased when it is combined with mitotane.


The serum concentration of ADINAZOLAM can be decreased when it is combined with Deferasirox.


The serum concentration of SOFOSBUVIR can be decreased when it is combined with norethindrone.


The serum concentration of nortriptyline can be decreased when it is combined with Deferasirox.


The serum concentration of vincristine can be decreased when it is combined with Deferasirox.


The serum concentration of Retigabine can be decreased when it is combined with carbamazepine.


The serum concentration of methylprednisolone can be decreased when it is combined with pentobarbital.


The serum concentration of zafirlukast can be decreased when it is combined with Deferasirox.


The serum concentration of PREDNICARBATE can be decreased when it is combined with phenytoin.


The serum concentration of gabapentin can be decreased when it is combined with CALCIUM CARBONATE.


The serum concentration of Ribociclib can be decreased when it is combined with nevirapine.


The serum concentration of abacavir can be decreased when it is combined with Darunavir.


The serum concentration of Maraviroc can be decreased when it is combined with Lumacaftor.


The serum concentration of CARTEOLOL can be decreased when it is combined with RIFAPENTINE.


The serum concentration of mifepristone can be decreased when it is combined with RIFAPENTINE.


The serum concentration of CLOCORTOLONE can be decreased when it is combined with RIFAPENTINE.


The serum concentration of pergolide can be decreased when it is combined with Enzalutamide.


The serum concentration of deferiprone can be decreased when it is combined with Iron sucrose.


The serum concentration of naloxone can be decreased when it is combined with Enzalutamide.


The serum concentration of propafenone can be decreased when it is combined with Enzalutamide.


The serum concentration of ifosfamide can be decreased when it is combined with Enzalutamide.


The serum concentration of Palonosetron can be decreased when it is combined with Bosentan.


The serum concentration of gentamicin can be decreased when it is combined with azlocillin.


The serum concentration of VORTIOXETINE can be decreased when it is combined with mitotane.


The serum concentration of xylometazoline can be decreased when it is combined with Rifampicin.


The serum concentration of hexylresorcinol can be decreased when it is combined with chloroquine.


The serum concentration of cannabidiol can be decreased when it is combined with mitotane.


The serum concentration of ceritinib can be decreased when it is combined with mitotane.


The serum concentration of Imatinib can be decreased when it is combined with mitotane.


The serum concentration of ethinyl estradiol can be decreased when it is combined with Aprepitant.


The serum concentration of Vitamin D3 can be decreased when it is combined with Enzalutamide.


The serum concentration of BISOPROLOL can be decreased when it is combined with mitotane.


The serum concentration of RIFABUTIN can be decreased when it is combined with mitotane.


The serum concentration of PARAMETHADIONE can be decreased when it is combined with mitotane.


The serum concentration of Spectinomycin can be decreased when it is combined with ampicillin.


The serum concentration of Clodronic Acid can be decreased when it is combined with Almasilate.


The serum concentration of Pitavastatin can be decreased when it is combined with Magnesium trisilicate.


The serum concentration of Ledipasvir can be decreased when it is combined with Aluminium.


The serum concentration of mestranol can be decreased when it is combined with mycophenolic acid.


The serum concentration of flumethasone can be decreased when it is combined with carbamazepine.


The serum concentration of PAMIDRONIC ACID can be decreased when it is combined with FERRIC CITRATE.


The serum concentration of Delavirdine can be decreased when it is combined with rabeprazole.


The serum concentration of chloramphenicol can be decreased when it is combined with Lumacaftor.


The serum concentration of OXTRIPHYLLINE can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of dienestrol can be decreased when it is combined with Asunaprevir.


The serum concentration of ETONOGESTREL can be decreased when it is combined with Enzalutamide.


The serum concentration of morphine can be decreased when it is combined with Enzalutamide.


The serum concentration of Ropivacaine can be decreased when it is combined with Enzalutamide.


The serum concentration of bupivacaine can be decreased when it is combined with Enzalutamide.


The serum concentration of Abemaciclib can be decreased when it is combined with Rifampicin.


The serum concentration of ritonavir can be decreased when it is combined with Fosphenytoin.


The serum concentration of furosemide can be decreased when it is combined with Aliskiren.


The serum concentration of SOFOSBUVIR can be decreased when it is combined with vinblastine.


The serum concentration of estrone can be decreased when it is combined with CYPROTERONE ACETATE.


The serum concentration of Imidafenacin can be decreased when it is combined with Vemurafenib.


The serum concentration of Elbasvir can be decreased when it is combined with Bosentan.


The serum concentration of SIMEPREVIR can be decreased when it is combined with RIFAPENTINE.


The serum concentration of nisoldipine can be decreased when it is combined with carbamazepine.


The serum concentration of GUANFACINE can be decreased when it is combined with RIFAPENTINE.


The serum concentration of Regorafenib can be decreased when it is combined with nevirapine.


The serum concentration of Tofacitinib can be decreased when it is combined with nevirapine.


The serum concentration of ethanol can be decreased when it is combined with Deferasirox.


The serum concentration of Saxagliptin can be decreased when it is combined with Deferasirox.


The serum concentration of Spectinomycin can be decreased when it is combined with nafcillin.


The serum concentration of Dabrafenib can be decreased when it is combined with mitotane.


The serum concentration of Pomalidomide can be decreased when it is combined with mitotane.


The serum concentration of Delavirdine can be decreased when it is combined with Saxagliptin.


The serum concentration of diethylstilbestrol can be decreased when it is combined with Saxagliptin.


The serum concentration of Levomilnacipran can be decreased when it is combined with mitotane.


The serum concentration of Panobinostat can be decreased when it is combined with RIFABUTIN.


The serum concentration of Benidipine can be decreased when it is combined with Rifaximin.


The serum concentration of cilnidipine can be decreased when it is combined with Rifaximin.


The serum concentration of mianserin can be decreased when it is combined with Enzalutamide.


The serum concentration of Apixaban can be decreased when it is combined with RIFABUTIN.


The serum concentration of plicamycin can be decreased when it is combined with TICARCILLIN.


The serum concentration of vincristine can be decreased when it is combined with cyclosporin A.


The serum concentration of Levobupivacaine can be decreased when it is combined with Deferasirox.


The serum concentration of Enasidenib can be decreased when it is combined with Dabrafenib.


The serum concentration of Clobetasone can be decreased when it is combined with Lumacaftor.


The serum concentration of gabapentin can be decreased when it is combined with efavirenz.


The serum concentration of Zoledronic acid can be decreased when it is combined with CALCIUM GLUCONATE.


The serum concentration of chenodeoxycholic acid can be decreased when it is combined with Dabrafenib.


The serum concentration of CLOCORTOLONE can be decreased when it is combined with Enzalutamide.


The serum concentration of CABAZITAXEL can be decreased when it is combined with Dabrafenib.


The serum concentration of benzyl alcohol can be decreased when it is combined with Dabrafenib.


The serum concentration of Naloxegol can be decreased when it is combined with Brigatinib.


The serum concentration of loperamide can be decreased when it is combined with Enzalutamide.


The serum concentration of theophylline can be decreased when it is combined with Asunaprevir.


The serum concentration of efavirenz can be decreased when it is combined with phenytoin.


The serum concentration of abacavir can be decreased when it is combined with Lopinavir.


The serum concentration of Levomilnacipran can be decreased when it is combined with Dabrafenib.


The serum concentration of Pomalidomide can be decreased when it is combined with Dabrafenib.


The serum concentration of minocycline can be decreased when it is combined with quinapril.


The serum concentration of estradiol can be decreased when it is combined with fosinopril.


The serum concentration of ouabain can be decreased when it is combined with metrizamide.


The serum concentration of DESOGESTREL can be decreased when it is combined with Fosaprepitant.


The serum concentration of clozapine can be decreased when it is combined with Teriflunomide.


The serum concentration of Telaprevir can be decreased when it is combined with Fluticasone furoate.


The serum concentration of propofol can be decreased when it is combined with Teriflunomide.


The serum concentration of GESTODENE can be decreased when it is combined with RIFABUTIN.


The serum concentration of doxycycline can be decreased when it is combined with Mephobarbital.


The serum concentration of cephalexin can be decreased when it is combined with Vemurafenib.


The serum concentration of ambroxol can be decreased when it is combined with Bosentan.


The serum concentration of ATOVAQUONE can be decreased when it is combined with efavirenz.


The serum concentration of nifedipine can be decreased when it is combined with efavirenz.


The serum concentration of Pazopanib can be decreased when it is combined with MAGNESIUM HYDROXIDE.


The serum concentration of Elvitegravir can be decreased when it is combined with Magaldrate.


The serum concentration of isoniazid can be decreased when it is combined with budesonide.


The serum concentration of Vemurafenib can be decreased when it is combined with Delafloxacin.


The serum concentration of cyclobenzaprine can be decreased when it is combined with Bosentan.


The serum concentration of kanamycin can be decreased when it is combined with azlocillin.


The serum concentration of Dabigatran etexilate can be decreased when it is combined with SODIUM BICARBONATE.


The serum concentration of Epirubicin can be decreased when it is combined with Pivmecillinam.


The serum concentration of promethazine can be decreased when it is combined with Lumacaftor.


The serum concentration of tolterodine can be decreased when it is combined with Bosentan.


The serum concentration of selegiline can be decreased when it is combined with Bosentan.


The serum concentration of Arbekacin can be decreased when it is combined with TICARCILLIN.


The serum concentration of amoxicillin can be decreased when it is combined with Lumacaftor.


The serum concentration of glipizide can be decreased when it is combined with Lumacaftor.


The serum concentration of Melatonin can be decreased when it is combined with Lumacaftor.


The serum concentration of ACENOCOUMAROL can be decreased when it is combined with ethanol.


The serum concentration of CEFPODOXIME can be decreased when it is combined with Aluminium hydroxide.


The serum concentration of medrysone can be decreased when it is combined with Lumacaftor.


The serum concentration of norethindrone can be decreased when it is combined with Deferasirox.


The serum concentration of diethylstilbestrol can be decreased when it is combined with Lumacaftor.


The serum concentration of atorvastatin can be decreased when it is combined with CALCIUM CARBONATE.


The serum concentration of Etidronic acid can be decreased when it is combined with CALCIUM CARBONATE.


The serum concentration of VALPROIC ACID can be decreased when it is combined with Lopinavir.


The serum concentration of Macitentan can be decreased when it is combined with Enzalutamide.


The serum concentration of Tiotropium can be decreased when it is combined with Enzalutamide.


The serum concentration of zidovudine can be decreased when it is combined with Darunavir.


The serum concentration of Aripiprazole can be decreased when it is combined with topotecan.


The serum concentration of Fosamprenavir can be decreased when it is combined with mitotane.


The serum concentration of hexylresorcinol can be decreased when it is combined with hydroxychloroquine.


The serum concentration of FLUTICASONE PROPIONATE can be decreased when it is combined with mitotane.


The serum concentration of LISURIDE can be decreased when it is combined with mitotane.


The serum concentration of Voriconazole can be decreased when it is combined with mitotane.


The serum concentration of enalapril can be decreased when it is combined with mitotane.


The serum concentration of diclofenac can be decreased when it is combined with mitotane.


The serum concentration of Coenzyme Q10 can be decreased when it is combined with CALCIUM CARBONATE.


The serum concentration of PAMIDRONIC ACID can be decreased when it is combined with Iron sucrose.


The serum concentration of glucosamine can be decreased when it is combined with Dabrafenib.


The serum concentration of Estrone sulfate can be decreased when it is combined with enalapril.


The serum concentration of losartan can be decreased when it is combined with Deferasirox.


The serum concentration of Halofantrine can be decreased when it is combined with Vemurafenib.


The serum concentration of dantrolene can be decreased when it is combined with Vemurafenib.


The serum concentration of estazolam can be decreased when it is combined with Vemurafenib.


The serum concentration of finasteride can be decreased when it is combined with Vemurafenib.


The serum concentration of Sunitinib can be decreased when it is combined with dexamethasone.


The serum concentration of Rilpivirine can be decreased when it is combined with famotidine.


The serum concentration of irinotecan can be decreased when it is combined with Rifampicin.


The serum concentration of Mometasone can be decreased when it is combined with Rifampicin.


The serum concentration of Coenzyme Q10 can be decreased when it is combined with Lumacaftor.


The serum concentration of Bortezomib can be decreased when it is combined with Fosphenytoin.


The serum concentration of clonazepam can be decreased when it is combined with mitotane.


The serum concentration of Lomitapide can be decreased when it is combined with Bosentan.


The serum concentration of acetyldigitoxin can be decreased when it is combined with kanamycin.


The serum concentration of estramustine can be decreased when it is combined with Elvitegravir.


The serum concentration of Canagliflozin can be decreased when it is combined with Lumacaftor.


The serum concentration of Fluticasone furoate can be decreased when it is combined with Lumacaftor.


The serum concentration of formestane can be decreased when it is combined with Lumacaftor.


The serum concentration of Bedaquiline can be decreased when it is combined with Lumacaftor.


The serum concentration of Trabectedin can be decreased when it is combined with RIFABUTIN.


The serum concentration of hydrocortisone can be decreased when it is combined with Bosentan.


The serum concentration of mestranol can be decreased when it is combined with Cobicistat.


The serum concentration of mycophenolic acid can be decreased when it is combined with MAGNESIUM OXIDE.


The serum concentration of Safinamide can be decreased when it is combined with Vemurafenib.


The serum concentration of ketoconazole can be decreased when it is combined with MAGNESIUM OXIDE.


The serum concentration of ZILEUTON can be decreased when it is combined with Bosentan.


The serum concentration of galanthamine can be decreased when it is combined with Deferasirox.


The serum concentration of tamoxifen can be decreased when it is combined with Deferasirox.


The serum concentration of diclofenac can be decreased when it is combined with Rifampicin.


The serum concentration of Erlotinib can be decreased when it is combined with Esomeprazole.


The serum concentration of busulfan can be decreased when it is combined with Deferasirox.


The serum concentration of leflunomide can be decreased when it is combined with osimertinib.


The serum concentration of hesperetin can be decreased when it is combined with osimertinib.


The serum concentration of Ibrutinib can be decreased when it is combined with Lumacaftor.


The serum concentration of letrozole can be decreased when it is combined with Deferasirox.


The serum concentration of Cabozantinib can be decreased when it is combined with primidone.


The serum concentration of Boceprevir can be decreased when it is combined with primidone.


The serum concentration of Idelalisib can be decreased when it is combined with Lumacaftor.


The serum concentration of Conivaptan can be decreased when it is combined with Brigatinib.


The serum concentration of rapamycin can be decreased when it is combined with Brigatinib.


The serum concentration of mestranol can be decreased when it is combined with Cilastatin.


The serum concentration of oxiconazole can be decreased when it is combined with Fosphenytoin.


The serum concentration of Fosamprenavir can be decreased when it is combined with Boceprevir.


The serum concentration of L-thyroxine can be decreased when it is combined with Aluminium hydroxide.


The serum concentration of Vismodegib can be decreased when it is combined with Bosentan.


The serum concentration of glipizide can be decreased when it is combined with mitotane.


The serum concentration of Flubendazole can be decreased when it is combined with hydroxychloroquine.


The serum concentration of oxybutynin can be decreased when it is combined with mitotane.


The serum concentration of quinidine can be decreased when it is combined with nisoldipine.


The serum concentration of Vitamin D3 can be decreased when it is combined with Dabrafenib.


The serum concentration of Riociguat can be decreased when it is combined with Aluminium hydroxide.


The serum concentration of Dolutegravir can be decreased when it is combined with Aluminium hydroxide.


The serum concentration of VALPROIC ACID can be decreased when it is combined with Asunaprevir.


The serum concentration of Elvitegravir can be decreased when it is combined with Bismuth subcitrate potassium.


The serum concentration of Estrone sulfate can be decreased when it is combined with Spirapril.


The serum concentration of Nintedanib can be decreased when it is combined with phenobarbital.


The serum concentration of Palbociclib can be decreased when it is combined with phenobarbital.


The serum concentration of Tasimelteon can be decreased when it is combined with phenobarbital.


The serum concentration of Olaparib can be decreased when it is combined with phenobarbital.


Amfepramone may decrease the sedative activities of mirtazapine.


benzphetamine may decrease the sedative activities of Dexchlorpheniramine maleate.


Lisdexamfetamine may decrease the sedative activities of tripelennamine.


Lisdexamfetamine may decrease the sedative activities of diphenhydramine.


MEPHENTERMINE may decrease the sedative activities of benztropine.


Lisdexamfetamine may decrease the sedative activities of CYCLIZINE.


AMPHETAMINE may decrease the sedative activities of flunarizine.


METHAMPHETAMINE may decrease the sedative activities of AZATADINE.


AMPHETAMINE may decrease the sedative activities of Dexbrompheniramine.


Lisdexamfetamine may decrease the sedative activities of clemastine.


benzphetamine may decrease the sedative activities of azelastine.


Amfepramone may decrease the sedative activities of epinastine.


Lisdexamfetamine may decrease the sedative activities of azelastine.


Amfepramone may decrease the sedative activities of azelastine.


hydroxyamphetamine may decrease the sedative activities of Phenindamine.


AMPHETAMINE may decrease the sedative activities of Lodoxamide.


MEPHENTERMINE may decrease the sedative activities of CYPROHEPTADINE.


Amfepramone may decrease the sedative activities of emedastine.


Lisdexamfetamine may decrease the sedative activities of mequitazine.


MEPHENTERMINE may decrease the sedative activities of Desloratadine.


dextroamphetamine may decrease the sedative activities of DIMENHYDRINATE.


AMPHETAMINE may decrease the sedative activities of pheniramine.


hydroxyamphetamine may decrease the sedative activities of AZATADINE.


MEPHENTERMINE may decrease the sedative activities of ACRIVASTINE.


dextroamphetamine may decrease the sedative activities of azelastine.


AMPHETAMINE may decrease the sedative activities of AZATADINE.


PSEUDOEPHEDRINE may decrease the sedative activities of meclizine.


benzphetamine may decrease the sedative activities of hydroxyzine.


METHAMPHETAMINE may decrease the sedative activities of CYPROHEPTADINE.


Lisdexamfetamine may decrease the sedative activities of triprolidine.


METHAMPHETAMINE may decrease the sedative activities of Levocetirizine.


hydroxyamphetamine may decrease the sedative activities of benztropine.


Lisdexamfetamine may decrease the sedative activities of cimetidine.


METHAMPHETAMINE may decrease the sedative activities of ACRIVASTINE.


MEPHENTERMINE may decrease the sedative activities of epinastine.


PSEUDOEPHEDRINE may decrease the sedative activities of triprolidine.


PSEUDOEPHEDRINE may decrease the sedative activities of ethopropazine.


METHAMPHETAMINE may decrease the sedative activities of DIMETHINDENE.


hydroxyamphetamine may decrease the sedative activities of Dexbrompheniramine.


Amfepramone may decrease the sedative activities of Chloropyramine.


Amfepramone may decrease the sedative activities of DIMETHINDENE.


Amfepramone may decrease the sedative activities of Isothipendyl.


Amfepramone may decrease the sedative activities of ROXATIDINE ACETATE.


hydroxyamphetamine may decrease the sedative activities of flunarizine.


Lisdexamfetamine may decrease the sedative activities of loratadine.


PSEUDOEPHEDRINE may decrease the sedative activities of epinastine.


METHAMPHETAMINE may decrease the sedative activities of famotidine.


METHAMPHETAMINE may decrease the sedative activities of ketotifen.


Amfepramone may decrease the sedative activities of hydroxyzine.


PSEUDOEPHEDRINE may decrease the sedative activities of promethazine.


hydroxyamphetamine may decrease the sedative activities of ROXATIDINE ACETATE.


Amfepramone may decrease the sedative activities of triprolidine.


hydroxyamphetamine may decrease the sedative activities of epinastine.


hydroxyamphetamine may decrease the sedative activities of Isothipendyl.


MEPHENTERMINE may decrease the sedative activities of antazoline.


hydroxyamphetamine may decrease the sedative activities of Chloropyramine.


hydroxyamphetamine may decrease the sedative activities of DIMETHINDENE.


Amfepramone may decrease the sedative activities of cetirizine.


dextroamphetamine may decrease the sedative activities of CYCLIZINE.


dextroamphetamine may decrease the sedative activities of meclizine.


MEPHENTERMINE may decrease the sedative activities of Dexchlorpheniramine maleate.


AMPHETAMINE may decrease the sedative activities of Mepyramine.


METHAMPHETAMINE may decrease the sedative activities of nizatidine.


hydroxyamphetamine may decrease the sedative activities of azelastine.


dextroamphetamine may decrease the sedative activities of Isothipendyl.


METHAMPHETAMINE may decrease the sedative activities of Phenindamine.


benzphetamine may decrease the sedative activities of meclizine.


benzphetamine may decrease the sedative activities of DIMENHYDRINATE.


benzphetamine may decrease the sedative activities of astemizole.


Amfepramone may decrease the sedative activities of Pemirolast.


dextroamphetamine may decrease the sedative activities of Alcaftadine.


Amfepramone may decrease the sedative activities of promethazine.


METHAMPHETAMINE may decrease the sedative activities of cinnarizine.


METHAMPHETAMINE may decrease the sedative activities of Dexbrompheniramine.


dextroamphetamine may decrease the sedative activities of mirtazapine.


benzphetamine may decrease the sedative activities of cinnarizine.


PSEUDOEPHEDRINE may decrease the sedative activities of cetirizine.


AMPHETAMINE may decrease the sedative activities of Levocetirizine.


AMPHETAMINE may decrease the sedative activities of epinastine.


MEPHENTERMINE may decrease the sedative activities of DIMENHYDRINATE.


dextroamphetamine may decrease the sedative activities of triprolidine.


hydroxyamphetamine may decrease the sedative activities of nizatidine.


Amfepramone may decrease the sedative activities of Alcaftadine.


Amfepramone may decrease the sedative activities of chlorpheniramine.


PSEUDOEPHEDRINE may decrease the sedative activities of chlorpheniramine.


PSEUDOEPHEDRINE may decrease the sedative activities of ranitidine.


AMPHETAMINE may decrease the sedative activities of ethopropazine.


benzphetamine may decrease the sedative activities of doxylamine.


Amfepramone may decrease the sedative activities of thonzylamine.


Lisdexamfetamine may decrease the sedative activities of Lodoxamide.


AMPHETAMINE may decrease the sedative activities of ACRIVASTINE.


hydroxyamphetamine may decrease the sedative activities of Buclizine.


MEPHENTERMINE may decrease the sedative activities of tripelennamine.


hydroxyamphetamine may decrease the sedative activities of tripelennamine.


dextroamphetamine may decrease the sedative activities of promethazine.


MEPHENTERMINE may decrease the sedative activities of hydroxyzine.


METHAMPHETAMINE may decrease the sedative activities of doxylamine.


Amfepramone may decrease the sedative activities of antazoline.


benzphetamine may decrease the sedative activities of emedastine.


Lisdexamfetamine may decrease the sedative activities of hydroxyzine.


Amfepramone may decrease the sedative activities of cinnarizine.


METHAMPHETAMINE may decrease the sedative activities of Pemirolast.


Lisdexamfetamine may decrease the sedative activities of doxylamine.


dextroamphetamine may decrease the sedative activities of Lodoxamide.


benzphetamine may decrease the sedative activities of trimeprazine.


Amfepramone may decrease the sedative activities of clemastine.


AMPHETAMINE may decrease the sedative activities of benztropine.


METHAMPHETAMINE may decrease the sedative activities of Desloratadine.


AMPHETAMINE may decrease the sedative activities of antazoline.


AMPHETAMINE may decrease the sedative activities of azelastine.


dextroamphetamine may decrease the sedative activities of mianserin.


benzphetamine may decrease the sedative activities of Alcaftadine.


dextroamphetamine may decrease the sedative activities of Dexchlorpheniramine maleate.


hydroxyamphetamine may decrease the sedative activities of CYPROHEPTADINE.


hydroxyamphetamine may decrease the sedative activities of Lodoxamide.


PSEUDOEPHEDRINE may decrease the sedative activities of Isothipendyl.


Amfepramone may decrease the sedative activities of trimeprazine.


Lisdexamfetamine may decrease the sedative activities of trimeprazine.


hydroxyamphetamine may decrease the sedative activities of antazoline.


flumazenil may decrease the sedative activities of zolpidem.


dextroamphetamine may decrease the sedative activities of ACRIVASTINE.


Amfepramone may decrease the sedative activities of Olopatadine.


PSEUDOEPHEDRINE may decrease the sedative activities of astemizole.


hydroxyamphetamine may decrease the sedative activities of chlorpheniramine.


Amfepramone may decrease the sedative activities of doxepin.


benzphetamine may decrease the sedative activities of Dexbrompheniramine.


METHAMPHETAMINE may decrease the sedative activities of tripelennamine.


benzphetamine may decrease the sedative activities of flunarizine.


MEPHENTERMINE may decrease the sedative activities of nizatidine.


hydroxyamphetamine may decrease the sedative activities of pheniramine.


benzphetamine may decrease the sedative activities of tripelennamine.


Amfepramone may decrease the sedative activities of ranitidine.


AMPHETAMINE may decrease the sedative activities of hydroxyzine.


Lisdexamfetamine may decrease the sedative activities of meclizine.


benzphetamine may decrease the sedative activities of Pemirolast.


Lisdexamfetamine may decrease the sedative activities of astemizole.


MEPHENTERMINE may decrease the sedative activities of cetirizine.


METHAMPHETAMINE may decrease the sedative activities of emedastine.


METHAMPHETAMINE may decrease the sedative activities of astemizole.


MEPHENTERMINE may decrease the sedative activities of azelastine.


METHAMPHETAMINE may decrease the sedative activities of Buclizine.


METHAMPHETAMINE may decrease the sedative activities of loratadine.


benzphetamine may decrease the sedative activities of benztropine.


METHAMPHETAMINE may decrease the sedative activities of ROXATIDINE ACETATE.


Lisdexamfetamine may decrease the sedative activities of Levocetirizine.


METHAMPHETAMINE may decrease the sedative activities of Isothipendyl.


METHAMPHETAMINE may decrease the sedative activities of Chloropyramine.


hydroxyamphetamine may decrease the sedative activities of trimeprazine.


hydroxyamphetamine may decrease the sedative activities of Olopatadine.


AMPHETAMINE may decrease the sedative activities of Pemirolast.


MEPHENTERMINE may decrease the sedative activities of promethazine.


dextroamphetamine may decrease the sedative activities of Chloropyramine.


dextroamphetamine may decrease the sedative activities of DIMETHINDENE.


dextroamphetamine may decrease the sedative activities of ROXATIDINE ACETATE.


dextroamphetamine may decrease the sedative activities of ranitidine.


PSEUDOEPHEDRINE may decrease the sedative activities of fexofenadine.


benzphetamine may decrease the sedative activities of Phenindamine.


dextroamphetamine may decrease the sedative activities of Mepyramine.


Lisdexamfetamine may decrease the sedative activities of benztropine.


METHAMPHETAMINE may decrease the sedative activities of Mepyramine.


dextroamphetamine may decrease the sedative activities of ethopropazine.


MEPHENTERMINE may decrease the sedative activities of Olopatadine.


hydroxyamphetamine may decrease the sedative activities of doxylamine.


MEPHENTERMINE may decrease the sedative activities of fexofenadine.


PSEUDOEPHEDRINE may decrease the sedative activities of hydroxyzine.


MEPHENTERMINE may decrease the sedative activities of cinnarizine.


PSEUDOEPHEDRINE may decrease the sedative activities of tripelennamine.


dextroamphetamine may decrease the sedative activities of antazoline.


Amfepramone may decrease the sedative activities of astemizole.


Lisdexamfetamine may decrease the sedative activities of cinnarizine.


dextroamphetamine may decrease the sedative activities of Levocetirizine.


Lisdexamfetamine may decrease the sedative activities of flunarizine.


hydroxyamphetamine may decrease the sedative activities of doxepin.


AMPHETAMINE may decrease the sedative activities of emedastine.


hydroxyamphetamine may decrease the sedative activities of Mepyramine.


Lisdexamfetamine may decrease the sedative activities of mianserin.


AMPHETAMINE may decrease the sedative activities of doxepin.


benzphetamine may decrease the sedative activities of chlorpheniramine.


PSEUDOEPHEDRINE may decrease the sedative activities of mequitazine.


flumazenil may decrease the sedative activities of zopiclone.


Amfepramone may decrease the sedative activities of ACRIVASTINE.


MEPHENTERMINE may decrease the sedative activities of Chloropyramine.


MEPHENTERMINE may decrease the sedative activities of DIMETHINDENE.


MEPHENTERMINE may decrease the sedative activities of Isothipendyl.


Amfepramone may decrease the sedative activities of DIMENHYDRINATE.


benzphetamine may decrease the sedative activities of epinastine.


Amfepramone may decrease the sedative activities of loratadine.


Amfepramone may decrease the sedative activities of Buclizine.


MEPHENTERMINE may decrease the sedative activities of Lodoxamide.


MEPHENTERMINE may decrease the sedative activities of mequitazine.


hydroxyamphetamine may decrease the sedative activities of Alcaftadine.


Lisdexamfetamine may decrease the sedative activities of chlorpheniramine.


hydroxyamphetamine may decrease the sedative activities of promethazine.


Amfepramone may decrease the sedative activities of meclizine.


hydroxyamphetamine may decrease the sedative activities of ranitidine.


PSEUDOEPHEDRINE may decrease the sedative activities of thonzylamine.


Amfepramone may decrease the sedative activities of diphenhydramine.


dextroamphetamine may decrease the sedative activities of cetirizine.


Amfepramone may decrease the sedative activities of mequitazine.


Amfepramone may decrease the sedative activities of CYCLIZINE.


METHAMPHETAMINE may decrease the sedative activities of hydroxyzine.


PSEUDOEPHEDRINE may decrease the sedative activities of Alcaftadine.


hydroxyamphetamine may decrease the sedative activities of thonzylamine.


PSEUDOEPHEDRINE may decrease the sedative activities of Buclizine.


flumazenil may decrease the sedative activities of Eszopiclone.


AMPHETAMINE may decrease the sedative activities of Olopatadine.


dextroamphetamine may decrease the sedative activities of hydroxyzine.


MEPHENTERMINE may decrease the sedative activities of Alcaftadine.


dextroamphetamine may decrease the sedative activities of tripelennamine.


dextroamphetamine may decrease the sedative activities of chlorpheniramine.


AMPHETAMINE may decrease the sedative activities of cinnarizine.


MEPHENTERMINE may decrease the sedative activities of ethopropazine.


Lisdexamfetamine may decrease the sedative activities of ROXATIDINE ACETATE.


Lisdexamfetamine may decrease the sedative activities of DIMETHINDENE.


Lisdexamfetamine may decrease the sedative activities of Isothipendyl.


MEPHENTERMINE may decrease the sedative activities of cimetidine.


METHAMPHETAMINE may decrease the sedative activities of Lodoxamide.


AMPHETAMINE may decrease the sedative activities of cetirizine.


AMPHETAMINE may decrease the sedative activities of Dexchlorpheniramine maleate.


Lisdexamfetamine may decrease the sedative activities of Dexchlorpheniramine maleate.


hydroxyamphetamine may decrease the sedative activities of meclizine.


PSEUDOEPHEDRINE may decrease the sedative activities of loratadine.


AMPHETAMINE may decrease the sedative activities of Phenindamine.


dextroamphetamine may decrease the sedative activities of mequitazine.


Lisdexamfetamine may decrease the sedative activities of thonzylamine.


hydroxyamphetamine may decrease the sedative activities of clemastine.


dextroamphetamine may decrease the sedative activities of fexofenadine.


METHAMPHETAMINE may decrease the sedative activities of ethopropazine.


Lisdexamfetamine may decrease the sedative activities of Dexbrompheniramine.


benzphetamine may decrease the sedative activities of pheniramine.


Lisdexamfetamine may decrease the sedative activities of mirtazapine.


MEPHENTERMINE may decrease the sedative activities of thonzylamine.


dextroamphetamine may decrease the sedative activities of pheniramine.


METHAMPHETAMINE may decrease the sedative activities of fexofenadine.


Lisdexamfetamine may decrease the sedative activities of Alcaftadine.


benzphetamine may decrease the sedative activities of Lodoxamide.


dextroamphetamine may decrease the sedative activities of thonzylamine.


MEPHENTERMINE may decrease the sedative activities of meclizine.


AMPHETAMINE may decrease the sedative activities of ranitidine.


MEPHENTERMINE may decrease the sedative activities of astemizole.


Amfepramone may decrease the sedative activities of Desloratadine.


Amfepramone may decrease the sedative activities of flunarizine.


MEPHENTERMINE may decrease the sedative activities of Mepyramine.


AMPHETAMINE may decrease the sedative activities of Alcaftadine.


hydroxyamphetamine may decrease the sedative activities of triprolidine.


AMPHETAMINE may decrease the sedative activities of chlorpheniramine.


MEPHENTERMINE may decrease the sedative activities of trimeprazine.


AMPHETAMINE may decrease the sedative activities of triprolidine.


METHAMPHETAMINE may decrease the sedative activities of meclizine.


PSEUDOEPHEDRINE may decrease the sedative activities of trimeprazine.


dextroamphetamine may decrease the sedative activities of astemizole.


PSEUDOEPHEDRINE may decrease the sedative activities of ACRIVASTINE.


PSEUDOEPHEDRINE may decrease the sedative activities of emedastine.


hydroxyamphetamine may decrease the sedative activities of ethopropazine.


benzphetamine may decrease the sedative activities of antazoline.


Lisdexamfetamine may decrease the sedative activities of fexofenadine.


Lisdexamfetamine may decrease the sedative activities of Phenindamine.


Amfepramone may decrease the sedative activities of Dexbrompheniramine.


Amfepramone may decrease the sedative activities of fexofenadine.


AMPHETAMINE may decrease the sedative activities of CYCLIZINE.


dextroamphetamine may decrease the sedative activities of loratadine.


hydroxyamphetamine may decrease the sedative activities of Pemirolast.


hydroxyamphetamine may decrease the sedative activities of emedastine.


Amfepramone may decrease the sedative activities of tripelennamine.


dextroamphetamine may decrease the sedative activities of epinastine.


MEPHENTERMINE may decrease the sedative activities of Buclizine.


Lisdexamfetamine may decrease the sedative activities of nizatidine.


hydroxyamphetamine may decrease the sedative activities of ACRIVASTINE.


benzphetamine may decrease the sedative activities of AZATADINE.


hydroxyamphetamine may decrease the sedative activities of hydroxyzine.


Lisdexamfetamine may decrease the sedative activities of AZATADINE.


hydroxyamphetamine may decrease the sedative activities of fexofenadine.


MEPHENTERMINE may decrease the sedative activities of ranitidine.


Lisdexamfetamine may decrease the sedative activities of ethopropazine.


METHAMPHETAMINE may decrease the sedative activities of cetirizine.


Amfepramone may decrease the sedative activities of Lodoxamide.


benzphetamine may decrease the sedative activities of cimetidine.


Amfepramone may decrease the sedative activities of famotidine.


AMPHETAMINE may decrease the sedative activities of meclizine.


PSEUDOEPHEDRINE may decrease the sedative activities of Dexchlorpheniramine maleate.


MEPHENTERMINE may decrease the sedative activities of diphenhydramine.


PSEUDOEPHEDRINE may decrease the sedative activities of doxylamine.


Amfepramone may decrease the sedative activities of ketotifen.


AMPHETAMINE may decrease the sedative activities of astemizole.


MEPHENTERMINE may decrease the sedative activities of CYCLIZINE.


MEPHENTERMINE may decrease the sedative activities of ROXATIDINE ACETATE.


PSEUDOEPHEDRINE may decrease the sedative activities of AZATADINE.


AMPHETAMINE may decrease the sedative activities of thonzylamine.


Lisdexamfetamine may decrease the sedative activities of epinastine.


MEPHENTERMINE may decrease the sedative activities of loratadine.


benzphetamine may decrease the sedative activities of CYPROHEPTADINE.


hydroxyamphetamine may decrease the sedative activities of cimetidine.


AMPHETAMINE may decrease the sedative activities of promethazine.


AMPHETAMINE may decrease the sedative activities of trimeprazine.


PSEUDOEPHEDRINE may decrease the sedative activities of Desloratadine.


PSEUDOEPHEDRINE may decrease the sedative activities of Pemirolast.


benzphetamine may decrease the sedative activities of cetirizine.


benzphetamine may decrease the sedative activities of Levocetirizine.


dextroamphetamine may decrease the sedative activities of trimeprazine.


PSEUDOEPHEDRINE may decrease the sedative activities of flunarizine.


AMPHETAMINE may decrease the sedative activities of DIMENHYDRINATE.


dextroamphetamine may decrease the sedative activities of emedastine.


PSEUDOEPHEDRINE may decrease the sedative activities of Dexbrompheniramine.


hydroxyamphetamine may decrease the sedative activities of mirtazapine.


PSEUDOEPHEDRINE may decrease the sedative activities of cinnarizine.


Amfepramone may decrease the sedative activities of mianserin.


MEPHENTERMINE may decrease the sedative activities of emedastine.


METHAMPHETAMINE may decrease the sedative activities of flunarizine.


PSEUDOEPHEDRINE may decrease the sedative activities of Olopatadine.


benzphetamine may decrease the sedative activities of promethazine.


flumazenil may decrease the sedative activities of Tasimelteon.


hydroxyamphetamine may decrease the sedative activities of CYCLIZINE.


Amfepramone may decrease the sedative activities of nizatidine.


PSEUDOEPHEDRINE may decrease the sedative activities of Lodoxamide.


PSEUDOEPHEDRINE may decrease the sedative activities of nizatidine.


PSEUDOEPHEDRINE may decrease the sedative activities of antazoline.


flumazenil may decrease the sedative activities of Suvorexant.


Lisdexamfetamine may decrease the sedative activities of cetirizine.


METHAMPHETAMINE may decrease the sedative activities of ranitidine.


flumazenil may decrease the sedative activities of zaleplon.


METHAMPHETAMINE may decrease the sedative activities of chlorpheniramine.


Amfepramone may decrease the sedative activities of Dexchlorpheniramine maleate.


PSEUDOEPHEDRINE may decrease the sedative activities of Chloropyramine.


PSEUDOEPHEDRINE may decrease the sedative activities of DIMETHINDENE.


PSEUDOEPHEDRINE may decrease the sedative activities of ROXATIDINE ACETATE.


hydroxyamphetamine may decrease the sedative activities of ketotifen.


METHAMPHETAMINE may decrease the sedative activities of benztropine.


hydroxyamphetamine may decrease the sedative activities of famotidine.


benzphetamine may decrease the sedative activities of Olopatadine.


Amfepramone may decrease the sedative activities of doxylamine.


hydroxyamphetamine may decrease the sedative activities of loratadine.


Lisdexamfetamine may decrease the sedative activities of antazoline.


dextroamphetamine may decrease the sedative activities of AZATADINE.


Lisdexamfetamine may decrease the sedative activities of promethazine.


Lisdexamfetamine may decrease the sedative activities of DIMENHYDRINATE.


PSEUDOEPHEDRINE may decrease the sedative activities of Mepyramine.


METHAMPHETAMINE may decrease the sedative activities of Olopatadine.


dextroamphetamine may decrease the sedative activities of Phenindamine.


PSEUDOEPHEDRINE may decrease the sedative activities of pheniramine.


benzphetamine may decrease the sedative activities of Desloratadine.


hydroxyamphetamine may decrease the sedative activities of mequitazine.


Amfepramone may decrease the sedative activities of Phenindamine.


hydroxyamphetamine may decrease the sedative activities of diphenhydramine.


METHAMPHETAMINE may decrease the sedative activities of thonzylamine.


Amfepramone may decrease the sedative activities of Mepyramine.


dextroamphetamine may decrease the sedative activities of Buclizine.


Lisdexamfetamine may decrease the sedative activities of Desloratadine.


hydroxyamphetamine may decrease the sedative activities of astemizole.


METHAMPHETAMINE may decrease the sedative activities of antazoline.


dextroamphetamine may decrease the sedative activities of flunarizine.


PSEUDOEPHEDRINE may decrease the sedative activities of Levocetirizine.


Lisdexamfetamine may decrease the sedative activities of pheniramine.


dextroamphetamine may decrease the sedative activities of Dexbrompheniramine.


dextroamphetamine may decrease the sedative activities of cinnarizine.


MEPHENTERMINE may decrease the sedative activities of Dexbrompheniramine.


benzphetamine may decrease the sedative activities of ranitidine.


dextroamphetamine may decrease the sedative activities of Olopatadine.


benzphetamine may decrease the sedative activities of ROXATIDINE ACETATE.


METHAMPHETAMINE may decrease the sedative activities of promethazine.


benzphetamine may decrease the sedative activities of Chloropyramine.


benzphetamine may decrease the sedative activities of DIMETHINDENE.


benzphetamine may decrease the sedative activities of Isothipendyl.


MEPHENTERMINE may decrease the sedative activities of mianserin.


benzphetamine may decrease the sedative activities of thonzylamine.


benzphetamine may decrease the sedative activities of ACRIVASTINE.


MEPHENTERMINE may decrease the sedative activities of flunarizine.


benzphetamine may decrease the sedative activities of Mepyramine.


PSEUDOEPHEDRINE may decrease the sedative activities of Phenindamine.


AMPHETAMINE may decrease the sedative activities of Chloropyramine.


AMPHETAMINE may decrease the sedative activities of DIMETHINDENE.


AMPHETAMINE may decrease the sedative activities of Isothipendyl.


AMPHETAMINE may decrease the sedative activities of ROXATIDINE ACETATE.


MEPHENTERMINE may decrease the sedative activities of Levocetirizine.


dextroamphetamine may decrease the sedative activities of Desloratadine.


METHAMPHETAMINE may decrease the sedative activities of triprolidine.


Lisdexamfetamine may decrease the sedative activities of emedastine.


dextroamphetamine may decrease the sedative activities of Pemirolast.


Lisdexamfetamine may decrease the sedative activities of CYPROHEPTADINE.


Lisdexamfetamine may decrease the sedative activities of Mepyramine.


benzphetamine may decrease the sedative activities of fexofenadine.


MEPHENTERMINE may decrease the sedative activities of Phenindamine.


AMPHETAMINE may decrease the sedative activities of fexofenadine.


METHAMPHETAMINE may decrease the sedative activities of mequitazine.


PSEUDOEPHEDRINE may decrease the sedative activities of famotidine.


PSEUDOEPHEDRINE may decrease the sedative activities of CYPROHEPTADINE.


PSEUDOEPHEDRINE may decrease the sedative activities of ketotifen.


Amfepramone may decrease the sedative activities of Levocetirizine.


dextroamphetamine may decrease the sedative activities of nizatidine.


AMPHETAMINE may decrease the sedative activities of tripelennamine.


METHAMPHETAMINE may decrease the sedative activities of pheniramine.


Amfepramone may decrease the sedative activities of benztropine.


flumazenil may decrease the sedative activities of Ramelteon.


PSEUDOEPHEDRINE may decrease the sedative activities of benztropine.


Amfepramone may decrease the sedative activities of AZATADINE.


Lisdexamfetamine may decrease the sedative activities of doxepin.


Lisdexamfetamine may decrease the sedative activities of ranitidine.


AMPHETAMINE may decrease the sedative activities of loratadine.


AMPHETAMINE may decrease the sedative activities of Buclizine.


Amfepramone may decrease the sedative activities of ethopropazine.


benzphetamine may decrease the sedative activities of ketotifen.


benzphetamine may decrease the sedative activities of famotidine.


benzphetamine may decrease the sedative activities of ethopropazine.


METHAMPHETAMINE may decrease the sedative activities of trimeprazine.


AMPHETAMINE may decrease the sedative activities of famotidine.


METHAMPHETAMINE may decrease the sedative activities of Alcaftadine.


AMPHETAMINE may decrease the sedative activities of ketotifen.


MEPHENTERMINE may decrease the sedative activities of famotidine.


Lisdexamfetamine may decrease the sedative activities of ketotifen.


Lisdexamfetamine may decrease the sedative activities of famotidine.


MEPHENTERMINE may decrease the sedative activities of ketotifen.


Lisdexamfetamine may decrease the sedative activities of Pemirolast.


Amfepramone may decrease the sedative activities of CYPROHEPTADINE.


MEPHENTERMINE may decrease the sedative activities of Pemirolast.


hydroxyamphetamine may decrease the sedative activities of cinnarizine.


dextroamphetamine may decrease the sedative activities of doxepin.


MEPHENTERMINE may decrease the sedative activities of doxylamine.


MEPHENTERMINE may decrease the sedative activities of clemastine.


PSEUDOEPHEDRINE may decrease the sedative activities of CYCLIZINE.


hydroxyamphetamine may decrease the sedative activities of Dexchlorpheniramine maleate.


hydroxyamphetamine may decrease the sedative activities of Desloratadine.


METHAMPHETAMINE may decrease the sedative activities of epinastine.


Amfepramone may decrease the sedative activities of pheniramine.


benzphetamine may decrease the sedative activities of loratadine.


dextroamphetamine may decrease the sedative activities of doxylamine.


dextroamphetamine may decrease the sedative activities of benztropine.


hydroxyamphetamine may decrease the sedative activities of DIMENHYDRINATE.


Lisdexamfetamine may decrease the sedative activities of ACRIVASTINE.


METHAMPHETAMINE may decrease the sedative activities of Dexchlorpheniramine maleate.


Lisdexamfetamine may decrease the sedative activities of Olopatadine.


dextroamphetamine may decrease the sedative activities of famotidine.


dextroamphetamine may decrease the sedative activities of CYPROHEPTADINE.


dextroamphetamine may decrease the sedative activities of ketotifen.


MEPHENTERMINE may decrease the sedative activities of chlorpheniramine.


AMPHETAMINE may decrease the sedative activities of nizatidine.


benzphetamine may decrease the sedative activities of nizatidine.


benzphetamine may decrease the sedative activities of triprolidine.


METHAMPHETAMINE may decrease the sedative activities of DIMENHYDRINATE.


benzphetamine may decrease the sedative activities of Buclizine.


MEPHENTERMINE may decrease the sedative activities of triprolidine.


hydroxyamphetamine may decrease the sedative activities of Levocetirizine.


hydroxyamphetamine may decrease the sedative activities of cetirizine.


AMPHETAMINE may decrease the sedative activities of Desloratadine.


METHAMPHETAMINE may decrease the sedative activities of CYCLIZINE.


hydroxyamphetamine may decrease the sedative activities of mianserin.


benzphetamine may decrease the sedative activities of mequitazine.


benzphetamine may decrease the sedative activities of diphenhydramine.


benzphetamine may decrease the sedative activities of CYCLIZINE.


PSEUDOEPHEDRINE may decrease the sedative activities of DIMENHYDRINATE.


Lisdexamfetamine may decrease the sedative activities of Buclizine.


METHAMPHETAMINE may decrease the sedative activities of azelastine.


Lisdexamfetamine may decrease the sedative activities of Chloropyramine.


MEPHENTERMINE may decrease the sedative activities of pheniramine.


Amfepramone may decrease the sedative activities of cimetidine.


MEPHENTERMINE may decrease the sedative activities of AZATADINE.


PSEUDOEPHEDRINE may decrease the sedative activities of azelastine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with bromocriptine.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Methylnaltrexone.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with timolol.


The serum concentration of the active metabolites of RIFABUTIN can be increased when RIFABUTIN is used in combination with nelfinavir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with AMPHETAMINE.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Vitamin D3.


The serum concentration of the active metabolites of tegafur can be increased when tegafur is used in combination with cimetidine.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Atazanavir.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with citalopram.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with isoniazid.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with vinorelbine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Crizotinib.


The serum concentration of the active metabolites of Propacetamol can be increased when Propacetamol is used in combination with metyrapone.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with nisoldipine.


The serum concentration of the active metabolites of Fosamprenavir can be increased when Fosamprenavir is used in combination with ketoconazole.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Idelalisib.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Pipotiazine.


The serum concentration of the active metabolites of carbamazepine can be increased when carbamazepine is used in combination with quetiapine.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Cinacalcet.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with fluvoxamine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Dasatinib.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Zucapsaicin.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Etoricoxib.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with sumatriptan.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with loratadine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with prednisone.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with indinavir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with bupropion.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with sildenafil.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with palmitic acid.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with desipramine.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Cobicistat.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with lomustine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with losartan.


The serum concentration of the active metabolites of theophylline can be increased when theophylline is used in combination with Febuxostat.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with rabeprazole.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with ritonavir.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with doxazosin.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with nelfinavir.


The serum concentration of the active metabolites of RIFABUTIN can be increased when RIFABUTIN is used in combination with Fosamprenavir.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with amprenavir.


The serum concentration of the active metabolites of clarithromycin can be increased when clarithromycin is used in combination with pentobarbital.


The serum concentration of the active metabolites of primidone can be increased when primidone is used in combination with methylphenidate.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with nefazodone.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with venlafaxine.


The serum concentration of the active metabolites of Temsirolimus can be increased when Temsirolimus is used in combination with ketoconazole.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with buspirone.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with trimethoprim.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with cimetidine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with acetaminophen.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Naloxegol.


The serum concentration of the active metabolites of Isavuconazonium can be increased when Isavuconazonium is used in combination with Posaconazole.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Dexmethylphenidate.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with astemizole.


The serum concentration of the active metabolites of CAPECITABINE can be increased when CAPECITABINE is used in combination with metronidazole.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Cobicistat.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with selegiline.


The serum concentration of the active metabolites of primidone can be increased when primidone is used in combination with Dexmethylphenidate.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Yohimbine.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with paroxetine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with estramustine.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with tioconazole.


The serum concentration of the active metabolites of Fosamprenavir can be increased when Fosamprenavir is used in combination with Voriconazole.


The serum concentration of the active metabolites of RIFABUTIN can be increased when RIFABUTIN is used in combination with ritonavir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with propofol.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with colchicine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with pravastatin.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Velpatasvir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with ticlopidine.


The serum concentration of the active metabolites of dyphylline can be increased when dyphylline is used in combination with Febuxostat.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with chlorpropamide.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Gefitinib.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Lumefantrine.


The serum concentration of the active metabolites of clarithromycin can be increased when clarithromycin is used in combination with carbamazepine.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Pioglitazone.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with cilazapril.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Imatinib.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with fluvastatin.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Candesartan cilexetil.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with doxorubicin.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Voriconazole.


The serum concentration of the active metabolites of Isavuconazonium can be increased when Isavuconazonium is used in combination with Telaprevir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with oxamniquine.


The serum concentration of the active metabolites of ifosfamide can be increased when ifosfamide is used in combination with RIFAPENTINE.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with labetalol.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Letermovir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with sertraline.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with quinidine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Fidaxomicin.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Telithromycin.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with morphine.


The serum concentration of the active metabolites of ifosfamide can be increased when ifosfamide is used in combination with Fosphenytoin.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with ketoconazole.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Midostaurin.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with pimozide.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with haloperidol.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with oxybutynin.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Desloratadine.


The serum concentration of the active metabolites of clarithromycin can be increased when clarithromycin is used in combination with primidone.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with nitrendipine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with triflupromazine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Caspofungin.


The serum concentration of the active metabolites of Isavuconazonium can be increased when Isavuconazonium is used in combination with ketoconazole.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with vinorelbine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with FLUPHENAZINE.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with felodipine.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Idelalisib.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with paroxetine.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with pimozide.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with erythromycin.


The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Boceprevir.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with GLYCEROL PHENYLBUTYRATE.


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with ranitidine.


The serum concentration of the active metabolites of Fosamprenavir can be increased when Fosamprenavir is used in combination with Posaconazole.


The serum concentration of the active metabolites of Isavuconazonium can be increased when Isavuconazonium is used in combination with indinavir.


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with cyclophosphamide.